These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 9243286)
21. Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression in rats. Chaux P; Favre N; Martin M; Martin F Int J Cancer; 1997 Aug; 72(4):619-24. PubMed ID: 9259401 [TBL] [Abstract][Full Text] [Related]
22. Dendritic cells can be used as physiological adjuvant in vivo. Moser M; Sornasse T; De Smedt T; Van Mechelen M; Heynderickx M; Flamand V; De Becker G; Thielemans K; Urbain J; Leo O Adv Exp Med Biol; 1995; 378():501-5. PubMed ID: 8526128 [No Abstract] [Full Text] [Related]
23. Expression of B7 costimulator molecules on mouse dendritic cells. Inaba K; Inaba M; Witmer-Pack M; Hatchcock K; Hodes R; Steinman RM Adv Exp Med Biol; 1995; 378():65-70. PubMed ID: 8526146 [TBL] [Abstract][Full Text] [Related]
24. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network. Bodey B; Bodey B; Kaiser HE In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303 [TBL] [Abstract][Full Text] [Related]
25. Costimulatory molecules in human atherosclerotic plaques: an indication of antigen specific T lymphocyte activation. de Boer OJ; Hirsch F; van der Wal AC; van der Loos CM; Das PK; Becker AE Atherosclerosis; 1997 Sep; 133(2):227-34. PubMed ID: 9298683 [TBL] [Abstract][Full Text] [Related]
26. Blocking of the B7-CD28 pathway increases the capacity of FasL+ (CD95L+) dendritic cells to kill alloactivated T cells. Lu L; Qian S; Starzl TE; Lynch DH; Thomson AW Adv Exp Med Biol; 1997; 417():275-82. PubMed ID: 9286373 [No Abstract] [Full Text] [Related]
27. Split activity of interleukin-10 on antigen capture and antigen presentation by human dendritic cells: definition of a maturative step. Morel AS; Quaratino S; Douek DC; Londei M Eur J Immunol; 1997 Jan; 27(1):26-34. PubMed ID: 9021994 [TBL] [Abstract][Full Text] [Related]
28. Human dendritic cells activate T lymphocytes via a CD40: CD40 ligand-dependent pathway. McLellan AD; Sorg RV; Williams LA; Hart DN Eur J Immunol; 1996 Jun; 26(6):1204-10. PubMed ID: 8647193 [TBL] [Abstract][Full Text] [Related]
29. The Toll-like receptor ligand MALP-2 stimulates dendritic cell maturation and modulates proteasome composition and activity. Link C; Gavioli R; Ebensen T; Canella A; Reinhard E; Guzmán CA Eur J Immunol; 2004 Mar; 34(3):899-907. PubMed ID: 14991620 [TBL] [Abstract][Full Text] [Related]
30. Anergic T cells inhibit the antigen-presenting function of dendritic cells. Vendetti S; Chai JG; Dyson J; Simpson E; Lombardi G; Lechler R J Immunol; 2000 Aug; 165(3):1175-81. PubMed ID: 10903714 [TBL] [Abstract][Full Text] [Related]
31. Initiation of the autologous mixed lymphocyte reaction requires the expression of costimulatory molecules B7-1 and B7-2 on human peripheral blood dendritic cells. Scheinecker C; Machold KP; Majdic O; Höcker P; Knapp W; Smolen JS J Immunol; 1998 Oct; 161(8):3966-73. PubMed ID: 9780165 [TBL] [Abstract][Full Text] [Related]
38. Phenotype and allostimulatory function of dendritic cells treated with antisense oligodeoxyribonucleotides targeting CD80 or CD86 mRNA. Liang X; Lu L; Zhang H; Vickers T; Fung JJ; Qian S Transplant Proc; 2001; 33(1-2):235. PubMed ID: 11266796 [No Abstract] [Full Text] [Related]
39. The role of CD40 and CD80 accessory cell molecules in dendritic cell-dependent HIV-1 infection. Pinchuk LM; Polacino PS; Agy MB; Klaus SJ; Clark EA Immunity; 1994 Jul; 1(4):317-25. PubMed ID: 7534204 [TBL] [Abstract][Full Text] [Related]
40. The expression of LFA-1, ICAM-1, CD80 and CD86 molecules in lupus patients: implication for immunotherapy. Takasaki Y; Abe K; Tokano Y; Hashimoto H Intern Med; 1999 Feb; 38(2):175-7. PubMed ID: 10225679 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]